Elicio Therapeutics (ELTX) Depreciation & Amortization (CF) (2020 - 2026)
Elicio Therapeutics posted quarterly Depreciation & Amortization (CF) of $46000.0 for Q1 2026, down 54.0% year-on-year from $100000.0 in Q1 2025, and up 2.22% on a QoQ basis from $45000.0 in Q4 2025.
Elicio Therapeutics (ELTX) has 7 years of Depreciation & Amortization (CF) data on file, last reported at $46000.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation & Amortization (CF) fell 54.0% year-over-year to $46000.0; the trailing twelve-month figure through Mar 2026 stood at $291000.0 (up 10.23% YoY), and the FY2025 full-year result was $200000.0, down 33.33% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $46000.0, up from $45000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $154000.0 in Q2 2022 and bottomed at $32000.0 in Q1 2022.
- The 5-year median for Depreciation & Amortization (CF) is $100000.0 (2022), against an average of $87266.7.
- The widest annual swing landed in 2022, when Depreciation & Amortization (CF) jumped 569.57%; it then tumbled 54.0% in 2026.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $90000.0 in 2022, then retreated by 8.89% to $82000.0 in 2023, then decreased by 21.95% to $64000.0 in 2024, then retreated by 29.69% to $45000.0 in 2025, then advanced by 2.22% to $46000.0 in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $46000.0 (Q1 2026), $45000.0 (Q4 2025), and $100000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 55.90 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 123.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 13.55 Mn |
| 10 | Elicio Therapeutics | 217.63 Mn | 202.68 Mn | - | 46,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46,000.00 |
| Mar 31, 2026 | 46,000.00 |
| Dec 31, 2025 | 45,000.00 |
| Dec 31, 2025 | 45,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 64,000.00 |
| Dec 31, 2024 | 64,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 82,000.00 |
| Mar 31, 2024 | 82,000.00 |
| Dec 31, 2023 | 82,000.00 |
| Dec 31, 2023 | 82,000.00 |
| Jun 30, 2023 | 104,000.00 |
| Jun 30, 2023 | 104,000.00 |
| Mar 31, 2023 | 110,000.00 |
| Mar 31, 2023 | 110,000.00 |
| Dec 31, 2022 | 90,000.00 |
| Dec 31, 2022 | 90,000.00 |
| Sep 30, 2022 | 100,000.00 |
| Sep 30, 2022 | 100,000.00 |
| Jun 30, 2022 | 154,000.00 |
| Jun 30, 2022 | 154,000.00 |
| Mar 31, 2022 | 32,000.00 |
| Mar 31, 2022 | 32,000.00 |
| Dec 31, 2021 | 32,000.00 |
| Dec 31, 2021 | 32,000.00 |
| Sep 30, 2021 | 23,000.00 |
| Sep 30, 2021 | 23,000.00 |
| Jun 30, 2021 | 23,000.00 |
| Jun 30, 2021 | 23,000.00 |
| Mar 31, 2021 | 6,000.00 |
| Mar 31, 2021 | 6,000.00 |
| Dec 31, 2020 | 14,000.00 |
| Dec 31, 2020 | 14,000.00 |
| Sep 30, 2020 | 47,000.00 |
| Sep 30, 2020 | 47,000.00 |
| Jun 30, 2020 | 47,000.00 |
| Jun 30, 2020 | 47,000.00 |
| Mar 31, 2020 | 27,000.00 |
| Mar 31, 2020 | 27,000.00 |